Patient-reported adverse events in PROSPECT, a randomized trial of chemotherapy with selective use of pelvic chemoradiation to standard use of chemoradiation for neoadjuvant treatment of locally advanced rectal cancer (Alliance N1048)
- Citation:
- J Clin Oncol vol 41 (supp 17) LBA2
- Meeting Instance:
- ASCO 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 4019
- Program:
- CCP
- Primary Committee:
- Health Outcomes
- Sec. Committees:
- GI
- Pharmas:
- Grants:
- UG1CA189823, U10CA180821, U10CA180882; U10CA180863, Canadian Cancer Society Grant # 707213 (CCTG); U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG); U01CA233046, HHSN261200800063C
- Corr. Author:
- Authors:
- Ethan Basch Amylou Dueck Sandra Mitchell Lauren Rogak Brenda Ginos Martin Weiser Harvey Mamon Lenoard Saltz George Chang Lori Minasian Andrea Denicoff Gita Thanarajasingam Doug Rubinson Brian Colgrove Rebecca Auer Thomas George Jeffrey Farma Eileen O'Reilly Jeffrey Meyerhardt Qian Shi Deborah Schrag
- Networks:
- LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, LAPS-TX035, PA086, SCOR
- Study
- NCCTG-N1048
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2/3
- Keywords: